Navigation Links
Vision Therapy Expert Announces Vision Therapy Best Treatment for Amblyopia
Date:6/27/2012

Gainesville, VA (PRWEB) June 27, 2012

According to the Bostons Children Hospital one in 50 or 2% of children develop a vision disorder called amblyopia, or “lazy eye”, undetected by standard eye examinations. Corrective lenses won’t treat the problem, but research indicates vision therapy can.

That’s why Dr. Tod Davis, a developmental optometrist with more than 30 years of clinical experience, recommends parents have their children screened for this disorder, and also exhorts them to have themselves screened if they had not been in the past. “There is a prevailing myth that you must catch amblyopia before the age of six in order for meaningful correction to be possible,” Dr. Davis says. “However, the truth is that this disorder is correctable at any age. We have had success with adults as well as children with our vision therapy methods.”

Amblyopia, not to be confused with crossed eyes, occurs when the brain fails to recognize the images received by one of the eyes. When one eye sees clearly and the other does not, the brain learns to ignore the eye with blurred vision and loss of vision occurs. Anything that interferes with vision may result in amblyopia. Untreated children run a greater risk of losing vision in the good eye.

“Children with this amblyopia often have problems with depth perception and seeing detail,” Dr. Davis said. “This is one of those eye disorders that can’t be treated with eyeglasses; fortunately, our vision therapy programs offer a high success rate of restoring normal eyesight. The earlier amblyopia is detected, the faster we can begin to treat it.”

Dr. Davis’ vision therapy begins with a thorough eye examination that determines how well the eyes work together. This examination goes beyond the standard eye chart assessment to evaluate how the eyes work up close and together, as well as how they move and how often they reverse letters or words. If someone is diagnosed with amblyopia, Dr. Davis creates an individualized therapy program designed to enhance the brain’s ability to control eye alignment, teaming, focusing, tracking and visual processing. Therapy typically lasts anywhere from six months to one year, with significant improvement taking place within the first four months.

About Dr. Tod Davis
Dr. Tod Davis Developmental Optometry and Vision Therapy Services offices are located in Gainesville, Fredericksburg and Winchester, Va. Dr. Davis is a developmental optometrist with over 30 years of experience treating people of all ages for a spectrum of different vision disorders, including convergence insufficiency, strabismus, amblyopia and vision-related reading difficulties. Visit DavisVisionTherapy.com for more information, patient forms and contact information.

Read the full story at http://www.prweb.com/releases/vision-therapy-dr-davis/lazy-eye-amblyopia/prweb9469669.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. VisionWare and Serco Partner to Enable ‘Digital by Default’ Strategy
2. US Drug Watchdog Now Offers To Help Every Recipient Of A DePuy Pinnacle Or Recalled DePuy ASR Hip Implant Who Had To Go Through Revision Surgery Get To The Best Lawyers
3. Oakworks Medical, a Division of Oakworks Inc., Oakworks.com, Manufacturer of Medical Tables and Positioning Devices Announces ISO 13485 Certification
4. Fatty acid found in fish prevents age-related vision loss: U of A medical research
5. Bascom Palmer Eye Institute announces breakthrough for degenerative vision disorder
6. Can a standard vision test predict nighttime driving performance?
7. International symposium on veterinary rehabilitation and physical therapy to be held in Vienna
8. Novel radiation therapy safely treats prostate cancer and lowers the risk of recurrence
9. Study suggests touch therapy helps reduce pain, nausea in cancer patients
10. Intensive cholesterol therapy with multiple drugs effective over long term
11. U.S.A. Hurdle Specialist Kellie Wells has Joined Elite Athletes Tiger Woods, Hines Ward and Takaishi Saito in Using Cell Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... MEDIA OPPORTUNITY: ... its rally to interview citizens on why they are rallying against Mayo Clinic. Specifically, ... to this effort against Dr. Noseworthy’s (CEO) decision to close the Albert Lea hospital. ...
(Date:9/22/2017)... York (PRWEB) , ... September 22, 2017 , ... ... and assembles Passive House buildings, and Richard Pedranti Architect (RPA), a ... House from the strategic partner’s Solsken Line of Model Homes . Independently, ...
(Date:9/22/2017)... ... September 22, 2017 , ... Happy Living’s mission - to improve the health ... into the entertaining and delicious worlds of theatre and wines. , After watching ... him to turn his play into a book. The Greener The Grass ( https://www.happyliving.com/books/the-greener-the-grass ...
(Date:9/22/2017)... Texas (PRWEB) , ... September 22, 2017 , ... ... network of independent freestanding emergency rooms is celebrating the one year anniversary of ... of our facility opening,” said Dr. Otinwa, Facility Medical Director of First Choice ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Letters From Home”: ... even the lost, have value to God. “Letters From Home” is the creation of ... member of the President’s Cabinet of Jerry Savelle Ministries International, who has traveled and ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... 5, 2017 Sapheneia and Scannerside received FDA ... DoseCheck is a third-party Vendor neutral CT product that ... allows compliance with current MITA standards. ... DoseCheck solution is specifically designed to provide CT operators, ... radiation doses over a predefined threshold. Scannerside Dose Check ...
(Date:9/5/2017)... WAYNE, N.J. , Sept. 5, 2017 /PRNewswire/ ... technology, has created a vibrant charitable donation program ... funds and support congenital heart defect research by ... healthcare providers and the general public are encouraged ... and submit the completed artwork to the ...
(Date:9/5/2017)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ... focused on the development of oral drug delivery systems, ... with the U.S. Food and Drug Administration (FDA) regarding ... At the meeting, the FDA ... of ORMD-0801, would be a Biologics License Application (BLA).  ...
Breaking Medicine Technology: